Clinical Trial Update: Stanford Coronary Risk Intervention Project (SCRIP) [Phase 3]

View source ↗

Summary

The Stanford Coronary Risk Intervention Project (SCRIP) is a Phase 3 trial sponsored by Stanford University that has completed, evaluating cardiovascular condit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Artery Disease
• Heart Disease
• Ischemic Heart Disease

Snippet

Sponsor: Stanford University | Conditions: Cardiovascular Diseases, Coronary Arteriosclerosis | Phase 3 | Status: COMPLETED